4.3 Article

The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights

Journal

CURRENT DIABETES REPORTS
Volume 12, Issue 3, Pages 280-285

Publisher

CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-012-0270-y

Keywords

Atherosclerotic vascular disease; Diabetes; Pathophysiological; Morphological

Funding

  1. National Health & Medical Research Council [565579]
  2. National Heart Foundation of Australia [PC0804045]
  3. Hanson Institute
  4. AstraZeneca
  5. Novartis
  6. Resverlogix
  7. Eli Lilly
  8. Anthera

Ask authors/readers for more resources

As the incidence of diabetes mellitus continues to rise, parallel increases in the rates of diabetic atherosclerotic vascular disease are projected to impart major health and socioeconomic challenges for authorities worldwide. Diabetes results in a proatherogenic phenotype, manifesting in an accelerated, diffuse, polyvascular fashion. In this review, we highlight the pathophysiological and morphological hallmarks of diabetic atherosclerosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available